{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:37:11Z","timestamp":1781624231231,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07348-8","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:19:31Z","timestamp":1765189171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-modal integration of histopathology and transcriptomics reveals STAB1+ macrophage-associated efferocytosis as a suppressive immune mechanism in colon adenocarcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhanhao","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongli","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2378-1220","authenticated-orcid":false,"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"7348_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"7348_CR2","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1097\/JS9.0000000000002262","volume":"111","author":"D Zeng","year":"2025","unstructured":"Zeng D, et al. Comparison of the efficacy of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients: meta-analysis of randomized controlled trials. Int J Surg. 2025;111:2686.","journal-title":"Int J Surg"},{"key":"7348_CR3","doi-asserted-by":"publisher","first-page":"101839","DOI":"10.1016\/j.cpsurg.2025.101839","volume":"70","author":"Q Li","year":"2025","unstructured":"Li Q, Lu Y, Wang D. Differential survival outcomes and prognostic factors across surgical approaches for colorectal cancer: analysis of 5000 patients from the seer database. Curr Probl Surg. 2025;70:101839.","journal-title":"Curr Probl Surg"},{"key":"7348_CR4","doi-asserted-by":"publisher","first-page":"101700","DOI":"10.1016\/j.cpsurg.2024.101700","volume":"63","author":"W Yu","year":"2025","unstructured":"Yu W, Lin Y, Huang M, Du Y, Ye Z. The connection between surgical margins in liver metastases from colorectal cancer and patient prognosis: a mini review. Curr Probl Surg. 2025;63:101700.","journal-title":"Curr Probl Surg"},{"key":"7348_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s10238-025-01751-7","volume":"25","author":"NS Sherafat","year":"2025","unstructured":"Sherafat NS, et al. Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective. Clin Exp Med. 2025;25:238.","journal-title":"Clin Exp Med"},{"key":"7348_CR6","doi-asserted-by":"publisher","first-page":"e008876","DOI":"10.1136\/jitc-2024-008876","volume":"13","author":"A Cesano","year":"2025","unstructured":"Cesano A, et al. Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review. J Immunother Cancer. 2025;13:e008876.","journal-title":"J Immunother Cancer"},{"key":"7348_CR7","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.ccell.2023.08.011","volume":"41","author":"Q Cai","year":"2023","unstructured":"Cai Q, et al. Building smart car T cell therapies: the path to overcome current challenges. Cancer Cell. 2023;41:1689\u201395.","journal-title":"Cancer Cell"},{"key":"7348_CR8","doi-asserted-by":"publisher","first-page":"1056622","DOI":"10.3389\/fimmu.2022.1056622","volume":"13","author":"W Mao","year":"2022","unstructured":"Mao W. Overcoming current challenges to T-cell receptor therapy via metabolic targeting to increase antitumor efficacy, durability, and tolerability. Front Immunol. 2022;13:1056622.","journal-title":"Front Immunol"},{"key":"7348_CR9","doi-asserted-by":"crossref","unstructured":"Kamrani A, et al. New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses. Cell Commun Signal. 2024;22.","DOI":"10.1186\/s12964-023-01430-8"},{"key":"7348_CR10","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.ccell.2023.08.002","volume":"41","author":"Transformer-based biomarker prediction from colorectal cancer histology:","year":"2023","unstructured":"Transformer-based biomarker prediction from colorectal cancer histology:A large-scale multicentric study. Cancer Cell. 2023;41:1650\u201361.e4.","journal-title":"Cancer Cell"},{"key":"7348_CR11","doi-asserted-by":"crossref","unstructured":"Chen Y, et al. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26(78).","DOI":"10.1186\/s12929-019-0568-z"},{"key":"7348_CR12","doi-asserted-by":"publisher","first-page":"217737","DOI":"10.1016\/j.canlet.2025.217737","volume":"624","author":"Cancer stem cells and tumor-associated macrophages:","year":"2025","unstructured":"Cancer stem cells and tumor-associated macrophages: Interactions and therapeutic opportunities. Cancer Lett. 2025;624:217737.","journal-title":"Cancer Lett"},{"key":"7348_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1042\/CS20210886","volume":"136","author":"P Hatthakarnkul","year":"2022","unstructured":"Hatthakarnkul P, et al. Molecular mechanisms of tumour budding and its association with microenvironment in colorectal cancer. Clin Sci. 2022;136:521\u201335.","journal-title":"Clin Sci"},{"key":"7348_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.61186\/ijbc.16.2.84","volume":"16","author":"SA Aghapour","year":"2024","unstructured":"Aghapour SA, et al. Investigating the dynamic interplay between cellular immunity and tumor cells in the fight against cancer: an updated comprehensive review. Iran J Blood Cancer. 2024;16:84\u2013101.","journal-title":"Iran J Blood Cancer"},{"key":"7348_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22:159.","journal-title":"Mol Cancer"},{"key":"7348_CR16","doi-asserted-by":"crossref","unstructured":"Zhou L, et al. Lipid droplet efferocytosis attenuates proinflammatory signaling in macrophages via TREM2- and MS4A7-dependent mechanisms. Cell Rep. 2025;44.","DOI":"10.1016\/j.celrep.2025.115310"},{"key":"7348_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.trsl.2025.05.002","volume":"281","author":"Mechanism of adipose-derived","year":"2025","unstructured":"Mechanism of adipose-derived stem cell-derived extracellular vesicles affecting macrophage efferocytosis by mediating ADAM17\/MerTK in the apoptosis of tubular epithelial cells after sepsis-associated acute kidney injury. Transl Res. 2025;281:14\u201330.","journal-title":"Transl Res"},{"key":"7348_CR18","doi-asserted-by":"crossref","unstructured":"Lin J, et al. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. OncoImmunology. 2022;11.","DOI":"10.1080\/2162402X.2021.2024941"},{"key":"7348_CR19","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1172\/JCI76375","volume":"124","author":"JC Stanford","year":"2014","unstructured":"Stanford JC, et al. Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. J Clin Invest. 2014;124:4737\u201352.","journal-title":"J Clin Invest"},{"key":"7348_CR20","doi-asserted-by":"crossref","unstructured":"Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated Efferocytosis. J Biol Chem. 2014;289:24560\u201372.","DOI":"10.1074\/jbc.M114.571620"},{"key":"7348_CR21","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1007\/s43032-024-01676-8","volume":"31","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Rajaei E, Sharifani MS, Aghaei M. Meta-analytical and meta-regression evaluation of subclinical Hyperthyroidism\u2019s effect on male reproductive health: hormonal and seminal perspectives. Reprod Sci Thousand Oaks Calif. 2024;31:2957\u201371.","journal-title":"Reprod Sci Thousand Oaks Calif"},{"key":"7348_CR22","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1007\/s00277-025-06387-x","volume":"104","author":"OS Aval","year":"2025","unstructured":"Aval OS, et al. Galectin-9: a double-edged sword in acute myeloid leukemia. Ann Hematol. 2025;104:3077\u201390.","journal-title":"Ann Hematol"},{"key":"7348_CR23","doi-asserted-by":"publisher","first-page":"e70191","DOI":"10.1002\/hsr2.70191","volume":"7","author":"M Torabizadeh","year":"2024","unstructured":"Torabizadeh M, et al. The association of nasal and blood eosinophils with serum IgE level in allergic rhinitis and asthma: a case-control study. Health Sci Rep. 2024;7:e70191.","journal-title":"Health Sci Rep"},{"key":"7348_CR24","doi-asserted-by":"crossref","unstructured":"PMFN-SSL: self-supervised learning-based progressive multimodal fusion network for cancer diagnosis and prognosis. Knowl-Based Syst. 2024;289:111502.","DOI":"10.1016\/j.knosys.2024.111502"},{"key":"7348_CR25","doi-asserted-by":"crossref","unstructured":"Feng B, et al. Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma. Npj Precis Oncol. 2025;9(57).","DOI":"10.1038\/s41698-025-00844-6"},{"key":"7348_CR26","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1158\/1078-0432.CCR-24-3656","volume":"31","author":"A Bjartell","year":"2025","unstructured":"Bjartell A, et al. Validation of a digital pathology-based multimodal artificial intelligence biomarker in a prospective, real-world prostate cancer cohort treated with prostatectomy. Clin Cancer Res. 2025;31:1546\u201353.","journal-title":"Clin Cancer Res"},{"key":"7348_CR27","doi-asserted-by":"publisher","unstructured":"Ganta L, Sinduja P, Priyadharshini R. Knowledge and awareness of the use of artificial intelligence in digital pathology. 2023 International Conference on Business Analytics for Technology and Security (ICBATS). 2023. pp. 1\u20136. https:\/\/doi.org\/10.1109\/ICBATS57792.2023.10111238.","DOI":"10.1109\/ICBATS57792.2023.10111238"},{"key":"7348_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/JS9.0000000000001875","volume":"111","author":"Y Yu","year":"2025","unstructured":"Yu Y, et al. Artificial intelligence-based multi-modal multi-tasks analysis reveals tumor molecular heterogeneity, predicts preoperative lymph node metastasis and prognosis in papillary thyroid carcinoma: a retrospective study. Int J Surg. 2025;111:839.","journal-title":"Int J Surg"},{"key":"7348_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12916-024-03482-0","volume":"22","author":"G-Y Ding","year":"2024","unstructured":"Ding G-Y, et al. Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning. BMC Med. 2024;22:282.","journal-title":"BMC Med"},{"key":"7348_CR30","doi-asserted-by":"crossref","unstructured":"A pathology-based diagnosis and prognosis intelligent system for oral squamous cell carcinoma using semi-supervised learning. Expert Syst Appl. 2024;254:124242.","DOI":"10.1016\/j.eswa.2024.124242"},{"key":"7348_CR31","doi-asserted-by":"crossref","unstructured":"A nested case-control study of serum polychlorinated biphenyls and papillary thyroid cancer risk among U.S. military service members. Environ Res. 2022;212:113367.","DOI":"10.1016\/j.envres.2022.113367"},{"key":"7348_CR32","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100.","journal-title":"Genome Biol"},{"key":"7348_CR33","doi-asserted-by":"crossref","unstructured":"Explainability-based graph augmentation for out-of-distribution robustness in digital pathology. Knowl-Based Syst. 2025;320:113640.","DOI":"10.1016\/j.knosys.2025.113640"},{"key":"7348_CR34","doi-asserted-by":"crossref","unstructured":"Gheibi Hayat SM, Bianconi V, Pirro M, Sahebkar A. Efferocytosis: molecular mechanisms and pathophysiological perspectives. Immunol Cell Biol. 2019;97:124\u201333.","DOI":"10.1111\/imcb.12206"},{"key":"7348_CR35","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.7150\/ijbs.91519","volume":"20","author":"C Fang","year":"2024","unstructured":"Fang C, et al. TREM2 promotes macrophage polarization from M1 to M2 and suppresses osteoarthritis through the NF-\u03baB\/CXCL3 axis. Int J Biol Sci. 2024;20:1992\u20132007.","journal-title":"Int J Biol Sci"},{"key":"7348_CR36","doi-asserted-by":"crossref","unstructured":"Zhao W, et al. M2-like TAMs function reversal contributes to breast cancer eradication by combination dual immune checkpoint blockade and photothermal therapy. Small. 2021;17.","DOI":"10.1002\/smll.202007051"},{"key":"7348_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2017.08.041","volume":"171","author":"Y Wang","year":"2017","unstructured":"Wang Y, et al. Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages. Cell. 2017;171:331\u201345.e22.","journal-title":"Cell"},{"key":"7348_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41423-024-01134-0","volume":"21","author":"Z Cai","year":"2024","unstructured":"Cai Z, et al. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through \u03b1-ketoglutarate and mTORC1 signaling. Cell Mol Immunol. 2024;21:448\u201365.","journal-title":"Cell Mol Immunol"},{"key":"7348_CR39","doi-asserted-by":"crossref","unstructured":"Evans F, et al. CD300f immune receptor contributes to healthy aging by regulating inflammaging, metabolism, and cognitive decline. Cell Rep. 2023;42.","DOI":"10.1016\/j.celrep.2023.113269"},{"key":"7348_CR40","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.1038\/s41467-024-54295-x","volume":"15","author":"S Elorbany","year":"2024","unstructured":"Elorbany S, et al. Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer. Nat Commun. 2024;15:10144.","journal-title":"Nat Commun"},{"key":"7348_CR41","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1084\/jem.20020327","volume":"196","author":"A-M Lennon-Dum\u00e9nil","year":"2002","unstructured":"Lennon-Dum\u00e9nil A-M, et al. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J Exp Med. 2002;196:529\u201340.","journal-title":"J Exp Med"},{"key":"7348_CR42","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.1108003","volume":"307","author":"L Delamarre","year":"2005","unstructured":"Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science. 2005;307:1630\u201334.","journal-title":"Science"},{"key":"7348_CR43","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1158\/1078-0432.CCR-18-3016","volume":"25","author":"M Viitala","year":"2019","unstructured":"Viitala M, et al. Immunotherapeutic blockade of macrophage clever-1 reactivates the CD8+ T-cell response against immunosuppressive tumors. Clin Cancer researchoff J Am Assoc Cancer Res. 2019;25:3289\u2013303.","journal-title":"Clin Cancer researchoff J Am Assoc Cancer Res"},{"key":"7348_CR44","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41388-018-0555-y","volume":"38","author":"A Karsch-Bluman","year":"2019","unstructured":"Karsch-Bluman A, et al. Tissue necrosis and its role in cancer progression. Oncogene. 2019;38:1920\u201335.","journal-title":"Oncogene"},{"key":"7348_CR45","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.7150\/ijbs.99680","volume":"20","author":"X Zhao","year":"2024","unstructured":"Zhao X, et al. A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells. Int J Biol Sci. 2024;20:5109\u201326.","journal-title":"Int J Biol Sci"},{"key":"7348_CR46","doi-asserted-by":"publisher","first-page":"109844","DOI":"10.1016\/j.celrep.2021.109844","volume":"37","author":"M Binnewies","year":"2021","unstructured":"Binnewies M, et al. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy. Cell Rep. 2021;37:109844.","journal-title":"Cell Rep"},{"key":"7348_CR47","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, et al. Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Cancer Res. 2022;82:3291\u2013306.","journal-title":"Cancer Res"},{"key":"7348_CR48","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/cas.70044","volume":"116","author":"J Yin","year":"2025","unstructured":"Yin J, Luo J, Wang L, Liu L, Liu L. STAB1 promotes acute myeloid leukemia progression by activating the IKK\/NF-\u03baB pathway and increasing M2 macrophage polarization. Cancer Sci. 2025;116:1508\u201321.","journal-title":"Cancer Sci"},{"key":"7348_CR49","doi-asserted-by":"publisher","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","volume":"115","author":"E Peranzoni","year":"2018","unstructured":"Peranzoni E, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci U.S.A. 2018;115:E4041\u201350.","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"7348_CR50","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u201358.","journal-title":"Nat Med"},{"key":"7348_CR51","doi-asserted-by":"crossref","unstructured":"Yu K, et al. Blockade of CLEVER-1 restrains immune evasion and enhances anti-PD-1 immunotherapy in gastric cancer. J Immunother Cancer. 2025;13.","DOI":"10.1136\/jitc-2024-011080"},{"key":"7348_CR52","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41416-020-0953-0","volume":"123","author":"M Hollm\u00e9n","year":"2020","unstructured":"Hollm\u00e9n M, Figueiredo CR, Jalkanen S. New tools to prevent cancer growth and spread: a \u2018Clever\u2019 approach. Br J Cancer. 2020;123:501\u201309.","journal-title":"Br J Cancer"},{"key":"7348_CR53","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1158\/1078-0432.CCR-20-4862","volume":"27","author":"R Virtakoivu","year":"2021","unstructured":"Virtakoivu R, et al. Systemic blockade of clever-1 elicits lymphocyte activation alongside checkpoint molecule downregulation in patients with solid tumors: results from a phase I\/II clinical trial. Clin Cancer Res. 2021;27:4205\u201320.","journal-title":"Clin Cancer Res"},{"key":"7348_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/2326-6066.CIR-23-0350","volume":"12","author":"JH Rannikko","year":"2024","unstructured":"Rannikko JH, Bono P, Hynninen J, Hollm\u00e9n M. Bexmarilimab activates human tumor-associated macrophages to support adaptive immune responses in interferon-poor immune microenvironments. Cancer Immunol Res. 2024;12:48\u201359.","journal-title":"Cancer Immunol Res"},{"key":"7348_CR55","doi-asserted-by":"publisher","first-page":"e011292","DOI":"10.1136\/jitc-2024-011292","volume":"13","author":"JH Rannikko","year":"2025","unstructured":"Rannikko JH, et al. Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment. J Immunother Cancer. 2025;13:e011292.","journal-title":"J Immunother Cancer"},{"key":"7348_CR56","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas AP. Adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168:707\u201323.","journal-title":"Cell"},{"key":"7348_CR57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/imm.12976","volume":"155","author":"L Cassetta","year":"2018","unstructured":"Cassetta L, Kitamura T. Macrophage targeting: opening new possibilities for cancer immunotherapy. Immunology. 2018;155:285\u201393.","journal-title":"Immunology"},{"key":"7348_CR58","doi-asserted-by":"crossref","unstructured":"Palani S, Elima K, Ekholm E, Jalkanen S, Salmi M. Monocyte stabilin-1 suppresses the activation of Th1 lymphocytes. J Immunol Baltim Md 1950. 2016;196:115\u201323.","DOI":"10.4049\/jimmunol.1500257"},{"key":"7348_CR59","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1158\/1078-0432.CCR-14-1236","volume":"20","author":"M Karikoski","year":"2014","unstructured":"Karikoski M, et al. Clever-1\/stabilin-1 controls cancer growth and metastasis. Clin Cancer researchoff J Am Assoc Cancer Res. 2014;20:6452\u201364.","journal-title":"Clin Cancer researchoff J Am Assoc Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07348-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07348-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07348-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:03:24Z","timestamp":1765195404000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07348-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7348"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07348-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board at Shengjing Hospital of China Medical University, Liaoning, P.R. China. Written informed consent was obtained from each patient for publication of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the journal\u2019s author agreement, carefully reviewed, and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest. All authors read the journal\u2019s policy on disclosure of potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"1386"}}